Zealand Pharma A/S (ZLDPF) Investment Research Dashboard
About Zealand Pharma A/S (ZLDPF) stock analysis
Get live ZLDPF stock price $46.52, comprehensive Zealand Pharma A/S stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time ZLDPF stock data and investment insights.
Loading chart data...
Zealand Pharma A/S (ZLDPF) Overview
Zealand Pharma A/S (ZLDPF) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, ZLDPF trades at $46.52 with a market capitalization of 3.29B . Over the past 52 weeks, ZLDPF has traded between $35.93 and $83.12 , with the current price positioned at approximately 22% of this range . The stock currently trades a...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 3.29B
- Current price: $46.52
- 52-week range: $35.93 - $83.12
- P/E ratio: 3.45
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Based in Copenhagen, Denmark, Zealand Pharma A/S operates as a biotechnology company dedicated to the entire lifecycle of peptide-based medicines – from their initial discovery and development through to their ultimate commercialization. Its therapeu...
Company Information
- CEO
- Adam Sinding Steensberg
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 544
Contact Information
- Address
- Sydmarken 11
- Country
- DK
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 3.5)
✓ Lower volatility stock (Beta: 0.59) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Zealand Pharma A/S shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Zealand Pharma A/S
- ⚠Investors should consider how Zealand Pharma A/S fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
3.29B
P/E Ratio (TTM)
3.45
Beta
0.59
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
80/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +5.7% | +6.1% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | +2.9% | +4.3% | 22.2 | 86/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +3.3% | +3.5% | 24.1 | 80/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.1% | -0.2% | 25.2 | 56/100⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.7% | +1.2% | 29.7 | 56/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | -0.1% | -1.6% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -5.8% | -5.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | -3.0% | -5.9% | 26.8 | 28/100⭐⭐ |
| Industrials | +0.6% | +1.7% | -11.2% | 30.1 | 26/100⭐⭐ |
| Consumer Cyclical | +0.5% | -0.4% | -6.3% | 43.0 | 21/100⭐ |
| Technology | +0.6% | -2.3% | -9.6% | 40.7 | 17/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.